JAMA Oncology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order
Journals package 3months
    http://medilib.ir
  • Duration of Time : 93 Day
  • Price : 100$
  • Special Price : 50$
Order

JAMA Oncology.

doi : 10.1001/jamaoncol.2024.4653

Volume 11(8) pgs. 822-922 August 2025

Buy The Package and View The Article Online


Buprenorphine for Cancer Pain-The Safest Opioid, and Patients With Cancer Cannot Get It.

doi : 10.1001/jamaoncol.2025.1337

Buy The Package and View The Article Online


Caring for Fasting Patients With Cancer During Ramadan.

doi : 10.1001/jamaoncol.2025.1585

Buy The Package and View The Article Online


A Paradigm Shift Toward Population-Based MRI-Targeted Prostate Cancer Screening.

doi : 10.1001/jamaoncol.2025.1594

Buy The Package and View The Article Online


Shifting Toward Precision Oncology in SCLC Treatment.

doi : 10.1001/jamaoncol.2025.1608

Buy The Package and View The Article Online


What Age Is the Best "FIT" for Colorectal Cancer Screening?.

doi : 10.1001/jamaoncol.2025.1361

Buy The Package and View The Article Online


Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors.

doi : 10.1001/jamaoncol.2025.1340

Buy The Package and View The Article Online


Long-Term Effectiveness Associated With Fecal Immunochemical Testing for Early-Age Screening.

doi : 10.1001/jamaoncol.2025.1433

Buy The Package and View The Article Online


Cancer Incidence and Trends in US Adults With HIV.

doi : 10.1001/jamaoncol.2025.1589

Buy The Package and View The Article Online


Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial.

doi : 10.1001/jamaoncol.2025.1597

Buy The Package and View The Article Online


Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial .

doi : 10.1001/jamaoncol.2025.1646

Buy The Package and View The Article Online


Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases: The U-BOMB Phase 2 Nonrandomized Clinical Trial.

doi : 10.1001/jamaoncol.2025.1694

Buy The Package and View The Article Online


Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial.

doi : 10.1001/jamaoncol.2025.1770

Buy The Package and View The Article Online


High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial.

doi : 10.1001/jamaoncol.2025.1779

Buy The Package and View The Article Online


Navigating Selective Dose Intensification in EGFR-Variant Non-Small Cell Lung Cancer.

doi : 10.1001/jamaoncol.2025.1768

Buy The Package and View The Article Online


Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical Trials.

doi : 10.1001/jamaoncol.2025.1394

Buy The Package and View The Article Online


Foot Lesions and Perianal Lump in an Adult Woman.

doi : 10.1001/jamaoncol.2025.1654

Buy The Package and View The Article Online


Foot Lesions and Perianal Lump in an Adult Woman.

doi : 10.1001/jamaoncol.2025.1654

Buy The Package and View The Article Online


Foot Lesions and Perianal Lump in an Adult Woman.

doi : 10.1001/jamaoncol.2025.1654

Buy The Package and View The Article Online


A Real-World Experience in Pan-Tumor Testing for HER2 IHC in More Than 65 000 Solid Tumors.

doi : 10.1001/jamaoncol.2025.1791

Buy The Package and View The Article Online


Tumor-Infiltrating Lymphocytes-An Area of Standardization.

doi : 10.1001/jamaoncol.2025.1849

Buy The Package and View The Article Online


Tumor-Infiltrating Lymphocytes-An Area of Standardization-Reply.

doi : 10.1001/jamaoncol.2025.1852

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?